Medtronic MiniMed 508 and Paradigm Series Insulin Pumps Improper Access Control
Vulnerability Description
Medtronic MiniMed Insulin Pumps are designed to communicate using a wireless RF with other devices, such as blood glucose meters, glucose sensor transmitters, and CareLink USB devices. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with adjacent access to one of the affected insulin pump models can inject, replay, modify, and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
Impact Analysis
Refer to official advisory for detailed impact metrics.
Remediation
Ensure systems are updated to the latest vendor-supplied patch levels.
Am I Vulnerable?
Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2019-10964
Credits & Attribution
The following person or organization is credited with identifying this vulnerability, as recorded in the NVD database:
- Based on earlier work performed by external researchers including Nathanael Paul, Jay Radcliffe, and Barnaby Jack, and from recent work performed by external researchers Billy Rios, Jonathan Butts, and Jesse Young, Medtronic performed additional variant analysis and reported this vulnerability
References
More from Medtronic
View All →Affected Vendor
Medtronic
View all reports →